CA
NZ
UK
AU
IND
US
…
Streamex Corp., a medical device technology company, provides advanced digital signal processing solutions for electrophysiology in the United States. The company offers the PURE EP platform, which delivers cardiac signal data to electrophysiologists during ablation procedures for the treatment of cardiovascular arrhythmias. It also develops and operates the Streamex Exchange platform, a blockchain-based platform that facilitates the tokenization and exchange of real-world assets for the tokenized gold market. In addition, the company offers software support, maintenance, and upgrade services. The company was formerly known as BioSig Technologies, Inc. and changed its name to Streamex Corp. in September 2025. Streamex Corp. was incorporated in 2009 and is headquartered in Winter Park, Florida.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -464.01M | -10.34M | -28.69M | -27.26M | -32.86M |
| Minority interest | -0.01M | 0.01M | -0.35M | 0.21M | 0.94M |
| Net income | -462.77M | -10.33M | -29.04M | -27.05M | -31.92M |
| Selling general administrative | 67.53M | 11.63M | 23.08M | 21.38M | 27.85M |
| Gross profit | - | 0.04M | 0.02M | 0.23M | 0.24M |
| Reconciled depreciation | 3.53M | 0.19M | 0.36M | 0.29M | 0.20M |
| Ebit | -462.42M | -12.61M | -28.51M | -27.27M | -33.41M |
| Ebitda | -458.89M | -12.42M | -28.15M | -26.97M | -33.21M |
| Depreciation and amortization | 3.53M | 0.19M | 0.36M | 0.29M | 0.20M |
| Operating income | -71.09M | -12.86M | -28.51M | -27.27M | -33.41M |
| Other operating expenses | 71.09M | 12.90M | 28.53M | 27.55M | 33.85M |
| Interest expense | 1.59M | 0.01M | - | - | - |
| Tax provision | -1.25M | 0.00M | 0.00M | 0.00M | 0.00M |
| Interest income | - | - | 0.01M | 0.00M | 0.00M |
| Net interest income | -1.59M | -0.01M | 0.01M | 0.00M | 0.00M |
| Income tax expense | -1.24M | - | - | - | - |
| Total revenue | 0.00M | 0.04M | 0.02M | 0.29M | 0.44M |
| Total operating expenses | 71.09M | 12.90M | 28.53M | 27.49M | 33.65M |
| Cost of revenue | - | - | 0.00M | 0.06M | 0.20M |
| Total other income expense net | -392.92M | 2.52M | -0.18M | 0.00M | 0.56M |
| Net income from continuing ops | -462.76M | -10.34M | -28.69M | -27.26M | -32.86M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 187.54M | 0.84M | 1.80M | 4.11M | 15.52M |
| Intangible assets | 44.64M | 0.27M | 0.29M | 0.31M | 0.33M |
| Other current assets | 41.81M | 0.08M | 0.21M | 0.33M | 0.35M |
| Total liab | 54.22M | 2.26M | 4.68M | 3.71M | 2.95M |
| Total stockholder equity | 133.19M | -1.44M | -2.91M | 0.42M | 12.35M |
| Other current liab | 4.77M | 2.16M | 4.22M | 2.94M | 2.26M |
| Common stock | 0.05M | 0.02M | 0.01M | 0.01M | 0.04M |
| Capital stock | 0.15M | 0.12M | 0.11M | 0.11M | 0.14M |
| Retained earnings | -718.12M | -255.34M | -245.01M | -215.97M | -188.92M |
| Good will | 70.98M | 0.00M | - | - | - |
| Cash | 20.32M | 0.14M | 0.19M | 0.36M | 11.66M |
| Total current liabilities | 42.79M | 2.26M | 4.58M | 3.26M | 2.58M |
| Current deferred revenue | - | - | 0.02M | 0.01M | 0.03M |
| Net debt | 17.70M | -0.04M | 0.26M | 0.41M | -11.00M |
| Short term debt | 38.02M | 0.10M | 0.35M | 0.31M | 0.28M |
| Short long term debt | 38.02M | - | - | - | - |
| Short long term debt total | 38.02M | 0.10M | 0.45M | 0.77M | 0.66M |
| Other stockholder equity | 850.45M | 253.78M | 241.99M | 216.28M | 201.13M |
| Total current assets | 71.89M | 0.34M | 0.53M | 1.13M | 13.89M |
| Short term investments | 9.71M | 0.01M | 0.10M | 0.10M | 0.00M |
| Net receivables | 0.06M | 0.11M | 0.02M | 0.01M | 0.00M |
| Inventory | - | - | 0.00M | 0.34M | 1.88M |
| Accumulated other comprehensive income | 0.81M | - | - | - | - |
| Non currrent assets other | - | 0.04M | 0.04M | 1.18M | 0.04M |
| Non current assets total | 115.65M | 0.50M | 1.27M | 2.98M | 1.62M |
| Capital lease obligations | 0.00M | 0.10M | 0.45M | 0.77M | 0.66M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | -24.62M | 0.00M | -0.19M | -0.17M | -0.54M |
| Total cashflows from investing activities | -24.25M | - | -0.19M | -0.17M | -0.54M |
| Net borrowings | 45.36M | 0.50M | 0.00M | - | - |
| Total cash from financing activities | 54.88M | 4.71M | 17.33M | 10.57M | 10.33M |
| Net income | -462.76M | -10.34M | -28.69M | -27.26M | -32.86M |
| Change in cash | 20.17M | -0.05M | -0.17M | -11.30M | -16.61M |
| Begin period cash flow | 0.14M | 0.19M | 0.36M | 11.66M | 28.27M |
| End period cash flow | 20.32M | 0.14M | 0.19M | 0.36M | 11.66M |
| Total cash from operating activities | -10.44M | -4.76M | -17.31M | -21.70M | -26.40M |
| Issuance of capital stock | 18.27M | 4.21M | 15.36M | 10.35M | 10.30M |
| Depreciation | 3.53M | 0.19M | 0.36M | 0.29M | 0.20M |
| Dividends paid | 0.01M | - | - | - | - |
| Change to inventory | - | 0.00M | -0.50M | 0.28M | -1.11M |
| Change to account receivables | -0.04M | 0.02M | 0.09M | -0.23M | 0.00M |
| Sale purchase of stock | 10.48M | - | - | - | - |
| Other cashflows from financing activities | -0.70M | - | 1.97M | 0.22M | 0.03M |
| Capital expenditures | 0.00M | 0.00M | 0.19M | 0.17M | 0.54M |
| Change in working capital | 0.07M | 0.36M | 0.77M | 0.46M | -3.45M |
| Stock based compensation | 57.10M | 6.96M | 7.98M | 4.41M | 9.50M |
| Other non cash items | 392.87M | -1.93M | 2.27M | 0.39M | 0.21M |
| Free cash flow | -10.44M | -4.76M | -17.50M | -21.87M | -26.94M |
Sector: Financial Services Industry: Capital Markets
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| STEX Streamex Corp |
-0.03 8.60% |
0.34 | - | - | 892.87 | 0.51 | 329.45 | -2.34 |
| GS Goldman Sachs Group Inc |
- -% |
910.19 | 17.21 | 16.00 | 4.47 | 2.26 | 11.15 | - |
| SCHW Charles Schwab Corp |
0.30 0.32% |
93.03 | 19.53 | 13.89 | 7.16 | 4.22 | 8.80 | - |
| MS Morgan Stanley |
-0.07 0.04% |
187.56 | 16.50 | 13.76 | 2.80 | 1.65 | - | - |
| IBKR Interactive Brokers Group Inc |
0.14 0.18% |
77.71 | 35.95 | 27.93 | 22.14 | 6.96 | 3.01 | 3.37 |
Streamex Corp., a medical device technology company, provides advanced digital signal processing solutions for electrophysiology in the United States. The company offers the PURE EP platform, which delivers cardiac signal data to electrophysiologists during ablation procedures for the treatment of cardiovascular arrhythmias. It also develops and operates the Streamex Exchange platform, a blockchain-based platform that facilitates the tokenization and exchange of real-world assets for the tokenized gold market. In addition, the company offers software support, maintenance, and upgrade services. The company was formerly known as BioSig Technologies, Inc. and changed its name to Streamex Corp. in September 2025. Streamex Corp. was incorporated in 2009 and is headquartered in Winter Park, Florida.
| Name | Title | Year Born |
|---|---|---|
| Mr. Morgan Lekstrom | Co-Founder & Interim Executive Chairman | 1986 |
| Mr. Karl Henry McPhie | Co-Founder, CEO & Director | 2000 |
| Mr. Mitchell Williams CFA | Chief Investment Officer | 1968 |
| Ms. Christine M. Plummer | CFO and Principal Accounting & Financial Officer | 1972 |
| Ms. Lora Mikolaitis | Chief Administrative Officer | 1973 |
| Ms. Laura Kiernan C.P.A. | Head of Investor Relations | NA |
| Mr. Michael Frisch | General Counsel | NA |
| Mr. Andrew Moskowitz | Head of BD & Partnerships | NA |
| Mr. Tai Long Singh | Head of Product | NA |
| Mr. Damion Simpkins | Head of Engineering | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-1.66%
Communication Services
-0.37%
Consumer Cyclical
-0.47%
Consumer Defensive
+0.06%
Energy
-0.06%
Financial Services
-0.32%
Financials
-2.20%
Healthcare
-0.89%
Industrials
-0.30%
Real Estate
-0.37%
Technology
-1.29%
Utilities
-0.59%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...